Delivery Order SPE2DR25D1205-SPE2DR26F0WE5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count unit) with a ceiling value of $3,734.00. This firm fixed-price delivery order is scheduled for completion by October 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) at a ceiling value of $1,030.76. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract specifies a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $2,710.84 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) on July 24, 2025, with completion scheduled for July 25, 2025. This is a firm fixed-price contract with no set-aside designation, awarded through open competition. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,133.12 to AmerisourceBergen Drug Corp for Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count supply) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed price, competitively awarded delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $1,512.92 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count unit). This is a firm fixed price delivery order with no set-aside designation, issued on September 2, 2025, with an ultimate completion date of September 3, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Esomeprazole Magnesium Delayed Release 40 mg capsules (30-count units) with a ceiling value of $3,199.68. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a $1,609.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for esomeprazole magnesium delayed-release 40 mg capsules (30-count supply) on September 12, 2025, with an ultimate completion date of September 15, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count units) valued at $1,066.56. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 26, 2025. This...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count units) with a ceiling value of $2,133.12. This delivery order represents a firm fixed-price, non-set-aside award and is scheduled for ultimate completion by September 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Esomeprazole Magnesium Delayed Release 40 mg capsules (30-count unit) with a ceiling value of $1,599.84. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competitive procurement. The order is set for ultimate completion by July 31, 2025, and will be performed at the contractor's facility in Conshohocken,...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0WE5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) with a ceiling value of $6,153.50. This contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's comprehensive IDC vehicle enables the delivery of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and generic drugs across multiple therapeutic domains. The current delivery order for Esomeprazole, a proton-pump inhibitor commonly used for gastrointestinal conditions, represents routine pharmaceutical supply fulfillment under this expansive contract framework with an ultimate completion date of November 5, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 11/4/25 |